688062.SS · 迈威生物
China A-shares · RS rating 3 · As of 2026-10-14
| Price | 22.90 CNY |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 3 / 15 / 15 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 5 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +45.0% |
| Distance from 52-week high | +55.3% |
| Market cap (USD) | $1.6B |